Spinal and Bulbar Muscular Atrophy
📧 Sign up to get email alerts when something new happens for Spinal and Bulbar Muscular Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
A clinical trial sponsored by NINDS is investigating clinical, molecular, and imaging biomarkers in Spinal and bulbar muscular atrophy (Kenn…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: International SBMA Project (KDA)
An update on the International SBMA Project (KDA) indicates the study is active but not recruiting, sponsored by Fondazione I.R.C.C.S. Istit…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: ALS/MND Natural History Study Data Repository
Clinical trial update announcing a natural history data repository study for ALS and related motor neuron diseases, with recruitment ongoing…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"
This update notes ongoing recruitment for an all-case investigation of leuprorelin acetate 11.25 mg injection kit for spinal and bulbar musc…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating mexiletine hydrochloride for spinal and bulbar muscular atrophy is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.